Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia
-
July 8, 2025
-
2 min
Original Source(s)
Related Content
Profitable Presbyopia
Presbyopia is no longer a condition we simply accommodate; it has become a platform for a longitudinal relationship that can span decades.
January 1, 2026
-
10 min
The Evolution of Treatments for Emmetropic Presbyopia
Often, these patients are unhappy with this reality check of aging and do not want to wear reading glasses, which is why practitioners and industry are always looking for ways to help. The challenge is to develop therapies that correct presbyopia while maintaining the emmetrope’s clear distance vision.
January 1, 2025
-
6 min
